Follow this page and receive
notifications about new suppliers
Bortezomib API Manufacturers
compare suppliers & get competitive offers
Date | Seller | Exporter country | Buyer | Importer country | Product | Quantity (KG) | Price per KG | Latest transactions |
|---|---|---|---|---|---|---|---|---|
| 30-Sep-2024 | (Hidden) | 
India
| LABORATORI... | 
Argentina
| BORTEZOMIB... | No data available | $ @36$-7! | Check all data |
| 30-Sep-2024 | (Hidden) |
India
| LABORATORI... |
Argentina
| BORTEZOMIB... | No data available | $ @36$-7! | |
| 30-Sep-2024 | (Hidden) |
India
| LABORATORI... |
Argentina
| BORTEZOMIB... | No data available | $ @36$-7! |
Filters
Reset current filters
Type
Production region
Qualifications
Country of origin
Follow us
Producer
Produced in:
Established in: 1989
MOQ: -
Employees: 5000+
6 production facilities approved by USFDA, AGES-Austria, PMDA, WHO
R&D Centers with capabilities of ANDAs, DMFs and NDDS
462+ patents filed for drug substances and polymorphs
+ 0
All certificates
Producer
+ 0
All certificates
Distributor
+ 0
All certificates
Producer
+ 0
All certificates
Producer
Produced in:
Established in: 1944
MOQ: -
Employees: 4,000
14 international API plant sites
Portfolio of 350+ APIs
Teva is among the world’s largest generic drug/API manufacturers
+ 0
All certificates
Producer
+ 0
All certificates
Producer
Produced in:
Established in: 2012
MOQ: 1 kg
Employees: 50+
Diverse portfolio of APIs and Nutra products
Focus on Hormones Oncology and Peptides with the highest quality
Leading manufacturer of ALpha Lipoic Acid
+ 0
All certificates
Producer
Produced in:
Established in: 2005
MOQ: -
Employees: 500
Platinum drugs rank Top 3 in the Chinese market
Dedicated to producing anti-cancer, anti-tumor, anti-fungal, and other APIs and Intermediates
Plants with GMP standard
+ 0
All certificates
Producer
+ 0
All certificates
Producer
+ 0
All certificates
Producer
+ 0
All certificates
Producer
+ 0
All certificates
Producer
+ 0
All certificates
Producer
+ 0
All certificates
Producer
+ 0
All certificates
Producer
+ 0
All certificates
Producer
+ 0
All certificates
Producer
+ 0
All certificates
Distributor
Produced in:
Established in: 1963
MOQ: -
Employees: 800+
World’s 1st exclusive API distributor
Portfolio of 600+ APIs
>250 clients in Europe
+ 0
All certificates
Producer
Produced in:
Established in: 1984
MOQ: -
Employees: 21,650
Diverse portfolio of 180+APIs
1754+ DMF across global markets
1100+ patents filed, and more than 70 own patents granted
+ 0
All certificates
Producer
+ 0
All certificates
Producer
+ 0
All certificates
Producer
+ 0
All certificates
Producer
+ 0
All certificates
Producer
+ 0
All certificates
Producer
+ 0
All certificates
How does it work?
You can register for free as long as you are registering on behalf of a legal company related to the pharmaceutical industry
Search in the search bar the product that you’re looking for. We’ll show you an overview of all available suppliers. Use the filters to select the relevant suppliers only
Have you found interesting suppliers? Then it’s time to contact them. Use the send inquiry button and send them a message. You can send for each product, 3 inquiries per week
Suppliers get notified by Pharmaoffer that they’ve received a new inquiry. They will come back to you with their questions, certificates, and offer in the chat on Pharmaoffer. We will send you an email in case of any news
Does the supplier meet your quality and commercial requirements? Then you can place the order. Just follow the steps of our order module
Looking for Bortezomib API 179324-69-7?
- Description:
- Here you will find a list of producers, manufacturers and distributors of Bortezomib. You can filter on certificates such as GMP, FDA, CEP, Written Confirmation and more. Send inquiries for free and get in direct contact with the supplier of your choice.
- API | Excipient name:
- Bortezomib
- Cas Number:
- 179324-69-7
- DrugBank number:
- DB00188
- Unique Ingredient Identifier:
- 69G8BD63PP
About Bortezomib
It's time for some technical information for the ones who understand chemistry: Bortezomib is a dipeptide boronic acid derivative and proteasome inhibitor used to treat multiple myeloma and mantle cell lymphoma. The 26S proteasome is a protein complex that degrades ubiquitinated proteins in the ubiquitin-proteasome pathway: reversible inhibition of the 26S proteasome, leading to cell cycle arrest and apoptosis of cancer cells, is thought to be the main mechanism of action of bortezomib. However, multiple mechanisms may be involved in the anticancer activity of bortezomib. Bortezomib was first synthesized in 1995.
You can ask the supplier for more technical information about the product.
Bortezomib is a type of Antineoplastics
Antineoplastics are a crucial category of pharmaceutical active pharmaceutical ingredients (APIs) primarily used in the treatment of cancer. These powerful substances inhibit or destroy the growth of cancer cells, thus impeding the progression of malignancies.
Antineoplastics exert their therapeutic effects through various mechanisms. Some APIs interfere with DNA replication, inhibiting the division and proliferation of cancer cells. Others target specific proteins or enzymes involved in tumor growth, effectively blocking their function. Additionally, certain antineoplastic agents induce programmed cell death, known as apoptosis, in cancer cells.
These APIs find application in a wide range of cancer treatments, including chemotherapy, targeted therapy, immunotherapy, and hormone therapy. They are often administered in combination with other drugs to optimize therapeutic outcomes and minimize drug resistance.
Antineoplastics are typically synthesized through complex chemical processes, ensuring high purity and potency. Stringent quality control measures are implemented throughout manufacturing to meet regulatory standards and ensure patient safety.
Although antineoplastics offer significant benefits in treating cancer, they can also cause adverse effects due to their cytotoxic nature. Common side effects include bone marrow suppression, gastrointestinal disturbances, hair loss, and immune system suppression. Close monitoring and supportive care are essential to manage these side effects effectively.
In conclusion, antineoplastics are a vital category of pharmaceutical APIs used in the treatment of cancer. Through their diverse mechanisms of action, these compounds play a critical role in combating malignancies and improving patient outcomes.
Bortezomib manufacturers | traders | suppliers
We have 26 companies offering Bortezomib produced in 7 different countries.
Get in contact with the supplier of your choice:
- Shilpa Medicare Ltd from India, product country of origin India
- Sionc Pharma from India, product country of origin India
- Flavine from Germany, product country of origin Unknown
- Jiangsu Hansoh Pharma from China, product country of origin China
- Teva API from Israel, product country of origin Unknown
- BDR Lifesciences from India, product country of origin India
- Avanscure Lifesciences Pvt Ltd from India, product country of origin India
- Shandong Boyuan from China, product country of origin China
- Lundbeck Pharma from Italy, product country of origin Italy
- Adley Formulations from India, product country of origin India
- Nippon Kayaku from Japan, product country of origin Japan
- Reliance Life Sciences from India, product country of origin India
- Zhejiang Hisun Pharma from China, product country of origin China
- H. Lundbeck from Denmark, product country of origin Denmark
- Shiratori Pharmaceutical from Japan, product country of origin Japan
- Laurus Labs from India, product country of origin India
- Chongqing Taihao from China, product country of origin China
- Natco Pharma from India, product country of origin India
- TIEFENBACHER API + Ingredients from Germany, product country of origin Unknown
- Dr. Reddy's from India, product country of origin India
- Polymed Therapeutics from United States, product country of origin United States
- Sun Pharma from India, product country of origin India
- ICROM from Italy, product country of origin Italy
- MSN Labs. from India, product country of origin India
- Biophore India from India, product country of origin India
- Hetero Labs from India, product country of origin India
Let the supplier know whether you are looking for a product with a specific monograph such as EP (Ph. Eur.), USP, JP, BP or another quality. Or, whether you are looking for hydrochloride (HCl), anhydricum, base, micronisatum or a specific purity.
You can use the filters to find high-quality suppliers. For example, you can select GMP, FDA or ISO certified suppliers. Visit our FAQ page or use the chat box in the corner to get more information about Pharmaoffer.
